Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design

Jifu Hao1, Xinsheng Fang2, Yanfang Zhou3, Jianzhu Wang1, Fengguang Guo1, Fei Li1, Xinsheng Peng31College of Pharmacy, Taishan Medical University, Taian, PR China; 2Agronomy Department of Shandong Agriculture University, Taian, PR China; 3School of pharmaceutical Sciences, Guangdong Medical College,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hao JF, Fang XS, Zhou YF, Wang JZ, Guo FG, Li F, Peng XS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/cecbdddf214547108e6d959e80e07fc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cecbdddf214547108e6d959e80e07fc9
record_format dspace
spelling oai:doaj.org-article:cecbdddf214547108e6d959e80e07fc92021-12-02T07:14:16ZDevelopment and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design1176-91141178-2013https://doaj.org/article/cecbdddf214547108e6d959e80e07fc92011-04-01T00:00:00Zhttp://www.dovepress.com/development-and-optimization-of-solid-lipid-nanoparticle-formulation-f-a7023https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Jifu Hao1, Xinsheng Fang2, Yanfang Zhou3, Jianzhu Wang1, Fengguang Guo1, Fei Li1, Xinsheng Peng31College of Pharmacy, Taishan Medical University, Taian, PR China; 2Agronomy Department of Shandong Agriculture University, Taian, PR China; 3School of pharmaceutical Sciences, Guangdong Medical College, Dongguan, PR ChinaAbstract: The purpose of the present study was to optimize a solid lipid nanoparticle (SLN) of chloramphenicol by investigating the relationship between design factors and experimental data using response surface methodology. A Box-Behnken design was constructed using solid lipid (X1), surfactant (X2), and drug/lipid ratio (X3) level as independent factors. SLN was successfully prepared by a modified method of melt-emulsion ultrasonication and low temperature-solidification technique using glyceryl monostearate as the solid lipid, and poloxamer 188 as the surfactant. The dependent variables were entrapment efficiency (EE), drug loading (DL), and turbidity. Properties of SLN such as the morphology, particle size, zeta potential, EE, DL, and drug release behavior were investigated, respectively. As a result, the nanoparticle designed showed nearly spherical particles with a mean particle size of 248 nm. The polydispersity index of particle size was 0.277 ± 0.058 and zeta potential was -8.74 mV. The EE (%) and DL (%) could reach up to 83.29% ± 1.23% and 10.11% ± 2.02%, respectively. In vitro release studies showed a burst release at the initial stage followed by a prolonged release of chloramphenicol from SLN up to 48 hours. The release kinetics of the optimized formulation best fitted the Peppas–Korsmeyer model. These results indicated that the chloramphenicol-loaded SLN could potentially be exploited as a delivery system with improved drug entrapment efficiency and controlled drug release.Keywords: chloramphenicol, solid lipid nanoparticle, Box-Behnken design, melt-emulsion ultrasonication and low temperature-solidification technique Hao JFFang XSZhou YFWang JZGuo FGLi FPeng XSDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2011, Iss default, Pp 683-692 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Hao JF
Fang XS
Zhou YF
Wang JZ
Guo FG
Li F
Peng XS
Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
description Jifu Hao1, Xinsheng Fang2, Yanfang Zhou3, Jianzhu Wang1, Fengguang Guo1, Fei Li1, Xinsheng Peng31College of Pharmacy, Taishan Medical University, Taian, PR China; 2Agronomy Department of Shandong Agriculture University, Taian, PR China; 3School of pharmaceutical Sciences, Guangdong Medical College, Dongguan, PR ChinaAbstract: The purpose of the present study was to optimize a solid lipid nanoparticle (SLN) of chloramphenicol by investigating the relationship between design factors and experimental data using response surface methodology. A Box-Behnken design was constructed using solid lipid (X1), surfactant (X2), and drug/lipid ratio (X3) level as independent factors. SLN was successfully prepared by a modified method of melt-emulsion ultrasonication and low temperature-solidification technique using glyceryl monostearate as the solid lipid, and poloxamer 188 as the surfactant. The dependent variables were entrapment efficiency (EE), drug loading (DL), and turbidity. Properties of SLN such as the morphology, particle size, zeta potential, EE, DL, and drug release behavior were investigated, respectively. As a result, the nanoparticle designed showed nearly spherical particles with a mean particle size of 248 nm. The polydispersity index of particle size was 0.277 ± 0.058 and zeta potential was -8.74 mV. The EE (%) and DL (%) could reach up to 83.29% ± 1.23% and 10.11% ± 2.02%, respectively. In vitro release studies showed a burst release at the initial stage followed by a prolonged release of chloramphenicol from SLN up to 48 hours. The release kinetics of the optimized formulation best fitted the Peppas–Korsmeyer model. These results indicated that the chloramphenicol-loaded SLN could potentially be exploited as a delivery system with improved drug entrapment efficiency and controlled drug release.Keywords: chloramphenicol, solid lipid nanoparticle, Box-Behnken design, melt-emulsion ultrasonication and low temperature-solidification technique
format article
author Hao JF
Fang XS
Zhou YF
Wang JZ
Guo FG
Li F
Peng XS
author_facet Hao JF
Fang XS
Zhou YF
Wang JZ
Guo FG
Li F
Peng XS
author_sort Hao JF
title Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
title_short Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
title_full Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
title_fullStr Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
title_full_unstemmed Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design
title_sort development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a box-behnken design
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/cecbdddf214547108e6d959e80e07fc9
work_keys_str_mv AT haojf developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT fangxs developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT zhouyf developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT wangjz developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT guofg developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT lif developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
AT pengxs developmentandoptimizationofsolidlipidnanoparticleformulationforophthalmicdeliveryofchloramphenicolusingaboxbehnkendesign
_version_ 1718399543420125184